Silence Therapeutics PLC (SLN NASDAQ) stock market data APIs
$6.959
0.33(4.7%)
as of May 7, 2026
Try our APIs with
free plan!
Silence Therapeutics PLC Financial Data Overview
Price chart is built with
Anychart
Silence Therapeutics plc, a biotechnology company, engages in the discovery and development of novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases. The company develops Divesiran (SLN124), which is in Phase 2 development for polycythemia vera, and SLN548 for complement-mediated renal diseases. It also develops Zerlasiran (SLN360) for cardiovascular disease associated with elevated lipoprotein(a); SLN312 for dyslipidemia; SLN365 for hypercholesterolemia; and SLN098 for obesity. The company was formerly known as SR Pharma plc and changed its name to Silence Therapeutics plc in May 2007. Silence Therapeutics plc was incorporated in 1994 and is headquartered in London, United Kingdom.
Prev. Close
6.959
Open
7.2888
High
7.3379
Low
6.6827
52 wk Range
3.6894-8.4
Market Cap
328 M
Shares Outstanding
47 235 K
Revenue
559 K
EPS
-0.27
Beta
1.515
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Silence Therapeutics PLC (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Silence Therapeutics PLC data using free add-ons & libraries
Get Silence Therapeutics PLC Fundamental Data
Silence Therapeutics PLC Fundamental data includes:
- Net Revenue: 559 K
- EBITDA: -81 735 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Silence Therapeutics PLC Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-03-18
- EPS/Forecast: -0.2017
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Silence Therapeutics PLC News
New
European Equities Traded in the US as American Depositary Receipts Heading Lower in Thursday Trading
European equities traded in the US as American depositary receipts were tracking lower late Thursday PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading
European equities traded in the US as American depositary receipts were lower late Wednesday morning PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
European Equities Traded in the US as American Depositary Receipts Edge Higher in Wednesday Trading
European equities traded in the US as American depositary receipts were higher late Wednesday mornin PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
European Equities Traded in the US as American Depositary Receipts Start Week on Flat Note in Monday Trading
European equities traded in the US as American depositary receipts began the week little changed lat PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
Get Silence Therapeutics PLC fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
